Study shows high efficacy rate for fecal transplants

04/13/2012 | Medscape (free registration)

Fecal transplants resolved recurrent Clostridium difficile infection in more than 90% of patients, according to a report in the American Journal of Gastroenterology. Montefiore Medical Center researchers said the study included long-term follow-up with patients who had followed an average of five unsuccessful courses of traditional treatments without success before having fecal transplantation. "FMT is a rational, durable, safe, and acceptable treatment option for patients with recurrent C. difficile infection," Dr. Lawrence J. Brandt and colleagues wrote.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health